Johnson & Johnson Price to Book Ratio 2010-2025 | JNJ
Historical price to book ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current price to book ratio for Johnson & Johnson as of June 18, 2025 is 4.69.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Johnson & Johnson Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2025-06-18 |
150.73 |
|
4.64 |
| 2025-03-31 |
164.43 |
$32.47 |
5.06 |
| 2024-12-31 |
142.26 |
$29.70 |
4.79 |
| 2024-09-30 |
158.14 |
$29.14 |
5.43 |
| 2024-06-30 |
141.55 |
$29.72 |
4.76 |
| 2024-03-31 |
151.97 |
$29.09 |
5.22 |
| 2023-12-31 |
149.45 |
$28.57 |
5.23 |
| 2023-09-30 |
147.32 |
$29.59 |
4.98 |
| 2023-06-30 |
155.43 |
$29.41 |
5.29 |
| 2023-03-31 |
144.47 |
$27.27 |
5.30 |
| 2022-12-31 |
163.47 |
$29.39 |
5.56 |
| 2022-09-30 |
150.20 |
$28.51 |
5.27 |
| 2022-06-30 |
162.12 |
$29.04 |
5.58 |
| 2022-03-31 |
160.83 |
$28.41 |
5.66 |
| 2021-12-31 |
154.25 |
$28.16 |
5.48 |
| 2021-09-30 |
144.68 |
$26.69 |
5.42 |
| 2021-06-30 |
146.71 |
$26.44 |
5.55 |
| 2021-03-31 |
145.45 |
$25.01 |
5.82 |
| 2020-12-31 |
138.42 |
$24.04 |
5.76 |
| 2020-09-30 |
130.04 |
$24.49 |
5.31 |
| 2020-06-30 |
122.02 |
$23.92 |
5.10 |
| 2020-03-31 |
113.00 |
$23.28 |
4.85 |
| 2019-12-31 |
124.90 |
$22.59 |
5.53 |
| 2019-09-30 |
110.02 |
$22.13 |
4.97 |
| 2019-06-30 |
117.56 |
$23.01 |
5.11 |
| 2019-03-31 |
117.19 |
$22.20 |
5.28 |
| 2018-12-31 |
107.47 |
$22.44 |
4.79 |
| 2018-09-30 |
114.34 |
$24.09 |
4.75 |
| 2018-06-30 |
99.74 |
$23.45 |
4.25 |
| 2018-03-31 |
104.57 |
$23.58 |
4.43 |
| 2017-12-31 |
113.28 |
$22.43 |
5.05 |
| 2017-09-30 |
104.77 |
$27.55 |
3.80 |
| 2017-06-30 |
105.93 |
$26.78 |
3.95 |
| 2017-03-31 |
99.08 |
$26.10 |
3.80 |
| 2016-12-31 |
91.04 |
$26.02 |
3.50 |
| 2016-09-30 |
92.71 |
$26.73 |
3.47 |
| 2016-06-30 |
94.57 |
$26.47 |
3.57 |
| 2016-03-31 |
83.76 |
$26.40 |
3.17 |
| 2015-12-31 |
78.94 |
$25.82 |
3.06 |
| 2015-09-30 |
71.22 |
$25.86 |
2.75 |
| 2015-06-30 |
73.79 |
$25.69 |
2.87 |
| 2015-03-31 |
75.61 |
$24.45 |
3.09 |
| 2014-12-31 |
78.05 |
$25.06 |
3.11 |
| 2014-09-30 |
79.04 |
$27.31 |
2.89 |
| 2014-06-30 |
77.06 |
$27.65 |
2.79 |
| 2014-03-31 |
71.85 |
$27.08 |
2.65 |
| 2013-12-31 |
66.52 |
$26.25 |
2.53 |
| 2013-09-30 |
62.52 |
$24.75 |
2.53 |
| 2013-06-30 |
61.46 |
$24.75 |
2.48 |
| 2013-03-31 |
57.93 |
$23.85 |
2.43 |
| 2012-12-31 |
49.41 |
$23.33 |
2.12 |
| 2012-09-30 |
48.15 |
$23.08 |
2.09 |
| 2012-06-30 |
46.78 |
$21.97 |
2.13 |
| 2012-03-31 |
45.23 |
$22.35 |
2.02 |
| 2011-12-31 |
44.58 |
$20.95 |
2.13 |
| 2011-09-30 |
42.89 |
$22.52 |
1.90 |
| 2011-06-30 |
44.40 |
$22.67 |
1.96 |
| 2011-03-31 |
39.21 |
$21.86 |
1.79 |
| 2010-12-31 |
40.56 |
$20.66 |
1.96 |
| 2010-09-30 |
40.29 |
$20.85 |
1.93 |
| 2010-06-30 |
38.04 |
$19.19 |
1.98 |
| 2010-03-31 |
41.62 |
$19.19 |
2.17 |
| 2009-12-31 |
40.80 |
$18.37 |
2.22 |
| 2009-09-30 |
38.27 |
$18.27 |
2.09 |
| 2009-06-30 |
35.41 |
$16.79 |
2.11 |
| 2009-03-31 |
32.51 |
$15.87 |
2.05 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$366.637B |
$88.821B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
